These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 23063401)
1. Synthesis and biological evaluation of novel heterocyclic derivatives of combretastatin A-4. Nguyen TT; Lomberget T; Tran NC; Colomb E; Nachtergaele L; Thoret S; Dubois J; Guillaume J; Abdayem R; Haftek M; Barret R Bioorg Med Chem Lett; 2012 Dec; 22(23):7227-31. PubMed ID: 23063401 [TBL] [Abstract][Full Text] [Related]
2. Synthesis, biological evaluation of 1,1-diarylethylenes as a novel class of antimitotic agents. Hamze A; Giraud A; Messaoudi S; Provot O; Peyrat JF; Bignon J; Liu JM; Wdzieczak-Bakala J; Thoret S; Dubois J; Brion JD; Alami M ChemMedChem; 2009 Nov; 4(11):1912-24. PubMed ID: 19790205 [TBL] [Abstract][Full Text] [Related]
3. Domino approach to 2-aroyltrimethoxyindoles as novel heterocyclic combretastatin A4 analogues. Arthuis M; Pontikis R; Chabot GG; Quentin L; Scherman D; Florent JC Eur J Med Chem; 2011 Jan; 46(1):95-100. PubMed ID: 21112130 [TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of resveratrol-based nitrovinylstilbenes as antimitotic agents. Reddy MA; Jain N; Yada D; Kishore C; Vangala JR; P Surendra R; Addlagatta A; Kalivendi SV; Sreedhar B J Med Chem; 2011 Oct; 54(19):6751-60. PubMed ID: 21851083 [TBL] [Abstract][Full Text] [Related]
5. Isoxazole-type derivatives related to combretastatin A-4, synthesis and biological evaluation. Kaffy J; Pontikis R; Carrez D; Croisy A; Monneret C; Florent JC Bioorg Med Chem; 2006 Jun; 14(12):4067-77. PubMed ID: 16510288 [TBL] [Abstract][Full Text] [Related]
6. 2-amino and 2'-aminocombretastatin derivatives as potent antimitotic agents. Chang JY; Yang MF; Chang CY; Chen CM; Kuo CC; Liou JP J Med Chem; 2006 Oct; 49(21):6412-5. PubMed ID: 17034147 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of 2- and 3-aminobenzo[b]thiophene derivatives as antimitotic agents and inhibitors of tubulin polymerization. Romagnoli R; Baraldi PG; Carrion MD; Lopez Cara C; Preti D; Fruttarolo F; Pavani MG; Tabrizi MA; Tolomeo M; Grimaudo S; Di Cristina A; Balzarini J; Hadfield JA; Brancale A; Hamel E J Med Chem; 2007 May; 50(9):2273-7. PubMed ID: 17419607 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of thiophene and benzo[b]thiophene analogs of combretastatin A-4 and isocombretastatin A-4: A comparison between the linkage positions of the 3,4,5-trimethoxystyrene unit. Do CV; Faouzi A; Barette C; Farce A; Fauvarque MO; Colomb E; Catry L; Berthier-Vergnes O; Haftek M; Barret R; Lomberget T Bioorg Med Chem Lett; 2016 Jan; 26(1):174-80. PubMed ID: 26602281 [TBL] [Abstract][Full Text] [Related]
9. Lead identification of conformationally restricted β-lactam type combretastatin analogues: synthesis, antiproliferative activity and tubulin targeting effects. Carr M; Greene LM; Knox AJ; Lloyd DG; Zisterer DM; Meegan MJ Eur J Med Chem; 2010 Dec; 45(12):5752-66. PubMed ID: 20933304 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and Biological Evaluation of 3-Alkyl-1,5-Diaryl-1H-Pyrazoles as Rigid Analogues of Combretastatin A-4 with Potent Antiproliferative Activity. Xu Q; Qi H; Sun M; Zuo D; Jiang X; Wen Z; Wang Z; Wu Y; Zhang W PLoS One; 2015; 10(6):e0128710. PubMed ID: 26061410 [TBL] [Abstract][Full Text] [Related]
11. Novel carbazole and acyl-indole antimitotics. Barta TE; Barabasz AF; Foley BE; Geng L; Hall SE; Hanson GJ; Jenks M; Ma W; Rice JW; Veal J Bioorg Med Chem Lett; 2009 Jun; 19(11):3078-80. PubMed ID: 19394222 [TBL] [Abstract][Full Text] [Related]
12. Concise synthesis and biological evaluation of 2-Aroyl-5-amino benzo[b]thiophene derivatives as a novel class of potent antimitotic agents. Romagnoli R; Baraldi PG; Lopez-Cara C; Preti D; Aghazadeh Tabrizi M; Balzarini J; Bassetto M; Brancale A; Fu XH; Gao Y; Li J; Zhang SZ; Hamel E; Bortolozzi R; Basso G; Viola G J Med Chem; 2013 Nov; 56(22):9296-309. PubMed ID: 24164557 [TBL] [Abstract][Full Text] [Related]
13. Novel A-ring and B-ring modified combretastatin A-4 (CA-4) analogues endowed with interesting cytotoxic activity. Simoni D; Romagnoli R; Baruchello R; Rondanin R; Grisolia G; Eleopra M; Rizzi M; Tolomeo M; Giannini G; Alloatti D; Castorina M; Marcellini M; Pisano C J Med Chem; 2008 Oct; 51(19):6211-5. PubMed ID: 18783207 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationships of 1-benzyl-4,5,6-trimethoxyindoles as a novel class of potent antimitotic agents. Lai MJ; Kuo CC; Yeh TK; Hsieh HP; Chen LT; Pan WY; Hsu KY; Chang JY; Liou JP ChemMedChem; 2009 Apr; 4(4):588-93. PubMed ID: 19266513 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and structure-activity relationships of constrained heterocyclic analogues of combretastatin A4. Arthuis M; Pontikis R; Chabot GG; Seguin J; Quentin L; Bourg S; Morin-Allory L; Florent JC ChemMedChem; 2011 Sep; 6(9):1693-705. PubMed ID: 21732536 [TBL] [Abstract][Full Text] [Related]
16. Antimitotic activity of structurally simplified biaryl analogs of the anticancer agents colchicine and combretastatin A4. McNulty J; van den Berg S; Ma D; Tarade D; Joshi S; Church J Bioorg Med Chem Lett; 2015 Jan; 25(1):117-21. PubMed ID: 25466200 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of 1-methyl-2-(3',4',5'-trimethoxybenzoyl)-3-aminoindoles as a new class of antimitotic agents and tubulin inhibitors. Romagnoli R; Baraldi PG; Sarkar T; Carrion MD; Cara CL; Cruz-Lopez O; Preti D; Tabrizi MA; Tolomeo M; Grimaudo S; Di Cristina A; Zonta N; Balzarini J; Brancale A; Hsieh HP; Hamel E J Med Chem; 2008 Mar; 51(5):1464-8. PubMed ID: 18260616 [TBL] [Abstract][Full Text] [Related]